2026-04-29T10:23:57-04:00 2024-12-31 264150644 ESCALON 2345 YALE1ST ST FL PALO ALTO CA 94306 990 2024-01-01 911608978 ACCESS TO ADVANCED HEALTH INSTITUTE ACCE 2063810883 222 5TH AVE N SEATTLE WA 98109 KEELEY FOLEY INTERIM CEO 2063810883 2026-04-29 false ELIZABETH ROBLES P00741189 4152343437 2026-04-29 2024 2025-03-06 01:10:19Z X X KEELEY FOLEY 222 5TH N AVENUE SEATTLE WA 98109 18401417 false X WWW.AAHI.ORG X 1993 WA THE CORPORATION IS ORGANIZED EXCLUSIVELY FOR CHARITABLE, SCIENTIFIC, LITERACY OR EDUCATIONAL PURPOSES, WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS HEREAFTER AMENDED (THE "CODE"). THE SPECIFIC PURPOSE IS RESEARCH IN THE FIELD OF INFECTIOUS DISEASES AND CANCERS AND THE DEVELOPMENT OF VACCINES, THERAPEUTICS, AND DIAGNOSTICS FOR SUCH DISEASES, AND TO TAKE SUCH OTHER ACTIONS, EITHER DIRECTLY OR THROUGH OTHER ORGANIZATIONS, AS ARE CONSISTENT WITH THESE PURPOSES AND WITH ITS TAX- EXEMPT STATUS UNDER SECTION 501(C)(3). 8 5 89 8 0 11574469 12565690 10631521 4362466 345516 308265 224869 1164996 22776375 18401417 0 0 11489626 11280651 0 0 12326239 24484620 23815865 35765271 -1039490 -17363854 39831178 20385832 14794761 12708130 25036417 7677702 false false 2811457 4670194 FORMULATIONS - ADJUVANTS ARE IMMUNE-STIMULATING MOLECULES THAT ENHANCE THE IMMUNE SYSTEM. AAHI ADJUVANT FORMULATIONS ARE USED FOR VACCINE DEVELOPMENT IN DISEASES SUCH AS TB, HIV, MALARIA AND OTHER INFECTIOUS DISEASES. 6312693 1870600 2876971 8299750 RNA VACCINES. AAHI RNA VACCINE PLATFORM IS BASED ON SELF- AMPLIFYING VACCINE TECHNOLOGY DELIVERED BY A NANOSTRUCTURED LIPID CARRIER. 811432 811432 12812553 true true false false false false false false false false true false false true true false true false false false false false false false false false false false false true false false false false false false false true false false false false true false false false false true 29 0 false 89 true false false false false false false false false X 8 5 true false false false false false false true true false false false true true false true true true true false ESCALON BUSINESS SERVICES 4152343437 2345 YALE 1ST STREET FL PALO ALTO CA 94306 CANDICE DECAIRE CHIEF STRATE 0.50 X 634562 0 0 COREY CASPER CEO, PRESIDE 0.50 X 516143 0 0 JERRY KUO CFO/COO 0.50 X 396150 0 0 ANNA MARIE BECKMANN EVP, PRODUCT 40.00 X 299448 0 0 CHRISTOPHER FOX SENIOR VP OF 40.00 X 263666 0 0 LINDA HAWKINS SENIOR DR. Q 40.00 X 246193 0 0 ROBRICK SMITH DIRECTOR, IN 40.00 X 215046 0 0 SUZAN SNODGRASS DIR. FINANCE 40.00 X 200054 0 0 ANDREW JOHNSON ASS. DIRECTO 40.00 X 196251 0 0 DARREN KLEMKOW DR. FACILITI 40.00 X 184366 0 0 EMILY VOIGT DR. RNA PROG 40.00 X 178112 0 0 LISA MCNEILL DR. MANUFACT 40.00 X 175014 0 0 ZACHARY SAGAWA DR. CLINICAL 40.00 X 173128 0 0 LISA BOUCHARD DR. QUALITY 40.00 X 170166 0 0 JEFFERY GUDERIAN DR. LABORATO 40.00 X 166204 0 0 DAMON PANG SENIOR CORPO 40.00 X 148533 0 0 RAOUL CONCEPCION BOARD MEMBER 0.50 X 54849 0 0 KEELEY FOLEY INTERIM CEO 0.50 X 10461 0 0 EDWARD HSU BOARD MEMBER 0.50 X 760 0 0 ROBERT APPELBAUM DIRECTOR 0.50 X 0 0 0 LINDA GAIL BEKKER DIRECTOR 0.50 X 0 0 0 CARLOS CORDON - CARDO DIRECTOR 0.50 X 0 0 0 GLENDA GRAY BORAD MEMBER 0.50 X 0 0 0 DAVID KERR BOARD MEMBER 0.50 X 0 0 0 EDWARD MOCARSKI BOARD MEMBER 0.50 X X 0 0 0 PATRICK SOON-SHIONG BOARD CHAIR 0.50 X X 0 0 0 4229106 16 true true false UNIVERSITY OF CALIFORNIA PO BOX 741816 LOS ANGELES CA 90074 SUB-CONTRACTORS 320902 COLORADO STATE UNIVERSITY FORT COLLINS FORT COLLINS CO 80523 SUB-CONTRACTORS 256087 REINHARD VEHRING 25 WILLOW STREET READING MA 01867 CONSULTING 225108 EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR ATLANTA GA 30322 SUB-CONTRACTORS 188631 UTMB AT GALVESTON OSP DEPT 750 PO BOX 660120 DALLAS TX 75266 SUB-CONTRACTORS 141042 5 12565690 12565690 LICENSING 1618950 1618950 REVENUE GMP PRODUCTS 989937 989937 NON FEDERAL CONTRACTS 927900 927900 CONSULTING & SERVICES REVENUE 493051 493051 REVENUE R&D MATERIALS 330607 330607 2021 2021 4362466 308265 308265 105866 105866 RENTAL INCOME 631069 631069 OTHER REVENUE 430215 430215 REALIZED GAIN/LOSS 300 300 -2454 -2454 1059130 18401417 5835727 10529816 5950727 4579089 33585 33585 717250 717250 4877755 1786343 3091412 298 298 78578 12719 65859 50351 340 50011 1486225 599002 887223 1116567 1116567 BAD DEBTS EXPENSES 8542289 108 8542181 RENT 2656835 2656835 LOSS ON ABANDONMENT OF 1198217 1198217 LAB SUPPLIES 1077543 1077543 3399962 3385771 14191 35765271 12812553 22952718 0 6910935 3388317 7634175 8000000 3252663 5893792 23493 554982 719340 649750 638083 22292310 17908713 5881470 4383597 1025031 959957 5922172 4379253 39831178 20385832 2740093 2271356 1311721 1283796 10742947 9152978 14794761 12708130 X 17036417 -322298 8000000 8000000 25036417 7677702 39831178 20385832 X -17363854 5139 X X false true X true false X 3584439 6701932 33420108 11574469 12565690 67846638 3584439 6701932 33420108 11574469 12565690 67846638 67846638 532 622450 833118 1131815 308265 2896180 12382 15171 12291 39844 193881 5587477 121629 7940 5910927 76693589 5835727 0.88460 0.55050 X PART II, LINE 10 5,910,927 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11377971 8922923 2455048 10914339 8985790 1928549 4383597 4379253 4379253 9152978 9152978 18401417 18401417 18401417 35765271 35765271 35765271 false false false false false false false false false CANDICE DECAIRE CHIEF STRATEGY OFFIC 634562 634562 COREY CASPER CEO, PRESIDENT 516143 516143 JERRY KUO CFO/COO 396150 396150 ANNA MARIE BECKMANN EVP, PRODUCT DEVLOPM 299448 299448 CHRISTOPHER FOX SENIOR VP OF FORMULA 263666 263666 LINDA HAWKINS SENIOR DR. QUALITY 246193 246193 ROBRICK SMITH DIRECTOR, INFOR. TEC 215046 215046 SUZAN SNODGRASS DIR. FINANCE 200054 200054 ANDREW JOHNSON ASS. DIRECTOR PRO. M 196251 196251 DARREN KLEMKOW DR. FACILITIES & PRO 184366 184366 EMILY VOIGT DR. RNA PROGRAMME 178112 178112 LISA MCNEILL DR. MANUFACTURING 175014 175014 ZACHARY SAGAWA DR. CLINICAL RESEARC 173128 173128 LISA BOUCHARD DR. QUALITY CONTROL 170166 170166 JEFFERY GUDERIAN DR. LABORATORY MANAG 166204 166204 IMMUNITY BIO BOARD MEMBER 10000 ANNUAL LICENSE false SCHEDULE L, PART V SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF PERSON: IMMUNITY BIO (B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: BOARD MEMBER >35% OWNER OF THE ORGANIZATION (C) AMOUNT OF TRANSACTION 6,574,703. (D) DESCRIPTION OF TRANSACTION: ANNUAL LICENSING AGREEMENT, CONTRACT SERVICES, PRODUCT & MATERIALS PROCEEDS (E) SHARING OF ORGANIZATION REVENUES? = NO FORM 990, PAGE 1, ITEM B UPDATING THE OFFICERS INFORMATION FORM 990 - ORGANIZATION'S MISSION OR MOST SIGNIFICANT ACTIVITES THE CORPORATION IS ORGANIZED EXCLUSIVELY FOR CHARITABLE, SCIENTIFIC, LITERACY OR EDUCATIONAL PURPOSES, WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS HEREAFTER AMENDED (THE "CODE"). THE SPECIFIC PURPOSE IS RESEARCH IN THE FIELD OF INFECTIOUS DISEASES AND CANCERS AND THE DEVELOPMENT OF VACCINES, THERAPEUTICS, AND DIAGNOSTICS FOR SUCH DISEASES, AND TO TAKE SUCH OTHER ACTIONS, EITHER DIRECTLY OR THROUGH OTHER ORGANIZATIONS, AS ARE CONSISTENT WITH THESE PURPOSES AND WITH ITS TAX- EXEMPT STATUS UNDER SECTION 501(C)(3). FORM 990, PAGE 1, PART I, LINE 6 ACCESS TO ADVANCED HEALTH INSTITUTE HAD EIGHT VOLUNTEER BOARD MEMBERS IN 2024. FORM 990, PAGE 6, PART VI, LINE 2 DR. PATRICK SOON SHIONG PROFESSOR DAVID KERR FORM 990, PAGE 6, PART VI, LINE 11B A DRAFT OF THE FORM 990 IS REVIEWED BY THE ESCALON. IN ADDITION, THE CHAIR OF THE FINANCE AND AUDIT COMMITTEE WILL REVIEW PRIOR TO FILING. FORM 990, PAGE 6, PART VI, LINE 15A THE BOARD ESTABLISHED A COMPENSATION COMMITTEE AND A COMPENSATION POLICY. COMPENSATION FOR THE CEO AND OTHER EXECUTIVE TEAM MEMBERS IS REVIEWED AND SET BY THE BOARD AFTER REVIEWING KEY PERFORMANCE INDICATORS FOR THE ORGANIZATION. FORM 990, PAGE 6, PART VI, LINE 19 REQUESTS FOR INFORMATION SUCH AS AUDITED FINANCIAL STATEMENTS AND GOVERNING DOCUMENTS ARE HANDLED THROUGH OUR FINANCE DEPARTMENT AND INFORMATION IS DISTRIBUTED AS REQUESTED UNLESS CONFIDENTIAL IN NATURE. REQUESTS FOR THE CONFLICT OF INTEREST POLICY ARE HANDLED THROUGH THE LEGAL DEPARTMENT. FORM 990, PART XI, LINE 9 OTHER INCREASE 5,139 FORM 990, PAGE 12, PART XII, LINE 3B AT THE TIME OF FILING FOR THE DECEMBER 31, 2024 FORM 990, ACCESS TO ADVANCED HEALTH INSTITUTE WAS UNDERGOING THE REQUIRED 2024 PROGRAM-SPECIFIC AUDIT. TIGER DEVELOPMENT LLC 3800 N CENTRAL AVE 460 PHOENIX AZ 85010 PATENT HOL AZ ACCESS TO ACCESS TO ADVANCED HEALTH INSTITUE